Open Access
Open access
Biomolecules, volume 12, issue 1, pages 93

The Sphingolipid Asset Is Altered in the Nigrostriatal System of Mice Models of Parkinson’s Disease

Publication typeJournal Article
Publication date2022-01-06
Journal: Biomolecules
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor5.5
ISSN2218273X
PubMed ID:  35053241
Biochemistry
Molecular Biology
Abstract

Parkinson’s disease (PD) is a neurodegenerative disease incurable due to late diagnosis and treatment. Therefore, one of the priorities of neurology is to study the mechanisms of PD pathogenesis at the preclinical and early clinical stages. Given the important role of sphingolipids in the pathogenesis of neurodegenerative diseases, we aimed to analyze the gene expression of key sphingolipid metabolism enzymes (ASAH1, ASAH2, CERS1, CERS3, CERS5, GBA1, SMPD1, SMPD2, UGCG) and the content of 32 sphingolipids (subspecies of ceramides, sphingomyelins, monohexosylceramides and sphinganine, sphingosine, and sphingosine-1-phosphate) in the nigrostriatal system in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse models of the preclinical and clinical stages of PD. It has been shown that in PD models, the expression of five of the nine studied genes (CERS1, CERS5, ASAH1, ASAH2, and GBA1) increases but only in the substantia nigra (SN) containing dopaminergic cell bodies. Changes in the expression of enzyme genes were accompanied by an increase in the content of 7 of the 32 studied sphingolipids. Such findings suggest these genes as attractive candidates for diagnostic purposes for preclinical and clinical stages of PD.

Citations by journals

1
Frontiers in Genetics
Frontiers in Genetics, 1, 50%
Frontiers in Genetics
1 publication, 50%
1

Citations by publishers

1
Frontiers Media S.A.
Frontiers Media S.A., 1, 50%
Frontiers Media S.A.
1 publication, 50%
1
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Blokhin V. et al. The Sphingolipid Asset Is Altered in the Nigrostriatal System of Mice Models of Parkinson’s Disease // Biomolecules. 2022. Vol. 12. No. 1. p. 93.
GOST all authors (up to 50) Copy
Blokhin V., Shupik M., Gutner U., Pavlova E., Lebedev A. T., Maloshitskaya O., Bogdanov V., Sokolov S., Alessenko A., Ugrumov M. The Sphingolipid Asset Is Altered in the Nigrostriatal System of Mice Models of Parkinson’s Disease // Biomolecules. 2022. Vol. 12. No. 1. p. 93.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/biom12010093
UR - https://doi.org/10.3390%2Fbiom12010093
TI - The Sphingolipid Asset Is Altered in the Nigrostriatal System of Mice Models of Parkinson’s Disease
T2 - Biomolecules
AU - Shupik, Maria
AU - Gutner, Ulyana
AU - Pavlova, Ekaterina
AU - Maloshitskaya, Olga
AU - Bogdanov, Vsevolod
AU - Sokolov, Sergey
AU - Alessenko, Alice
AU - Ugrumov, Michael
AU - Blokhin, Victor
AU - Lebedev, Albert T.
PY - 2022
DA - 2022/01/06 00:00:00
PB - Multidisciplinary Digital Publishing Institute (MDPI)
SP - 93
IS - 1
VL - 12
PMID - 35053241
SN - 2218-273X
ER -
BibTex |
Cite this
BibTex Copy
@article{2022_Blokhin,
author = {Maria Shupik and Ulyana Gutner and Ekaterina Pavlova and Olga Maloshitskaya and Vsevolod Bogdanov and Sergey Sokolov and Alice Alessenko and Michael Ugrumov and Victor Blokhin and Albert T. Lebedev},
title = {The Sphingolipid Asset Is Altered in the Nigrostriatal System of Mice Models of Parkinson’s Disease},
journal = {Biomolecules},
year = {2022},
volume = {12},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
month = {jan},
url = {https://doi.org/10.3390%2Fbiom12010093},
number = {1},
pages = {93},
doi = {10.3390/biom12010093}
}
MLA
Cite this
MLA Copy
Blokhin, Victor, et al. “The Sphingolipid Asset Is Altered in the Nigrostriatal System of Mice Models of Parkinson’s Disease.” Biomolecules, vol. 12, no. 1, Jan. 2022, p. 93. https://doi.org/10.3390%2Fbiom12010093.
Found error?